Catalyst Wire Dossier Catalyst Wire Dossier

Cholecalciferol (vitamin D3) supplementary treatment

cholecalciferol
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cholecalciferol (vitamin D3) supplementary treatment, covering 2017-12-14 to 2017-12-14. Get the full timeline:

Most recent: Clinical Trial Update: A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times Weekly [Phase 2]

See pricing